Skip to main content

Table 1 Showing blood counts and chemistry profiles

From: Mast cell leukemia associated with undefined morphology and chronic basophilic leukemia

Laboratory Findings

At Presentation

1. month

3. month

5. month

7. month

7,5. month

8. month

  (×10 9 /L)

       

White Blood Cells

4.6

59.0

170.0

19.0

149.0

250.0

315.0

Basophil count

2.6

36.5

79.9

9.8

77.4

 

122.8

Eosinophil count

-

-

4.5

5.3

4.1

 

-

Mast cell count

-

-

28.9

3.0

23.8

 

78.7

Platelet

134.0

157

80.0

43.0

43.9

 

41.0

Hgb (g/dL)

5.7

8.9

7.1

8.9

8.9

 

7.2

Manual Differential Counts (%)

       

Seg. Basophil

46

10

10

 

14

 

-

  Basophil Band

8

12

5

 

2

 

1

  Basophil Meta.

3

25

14

 

20

 

13

  Basophil Myelo.

-

15

18

 

16

 

25

  Promyelocyte

-

-

9

 

-

 

26

Eosinophilic series

29

6

27

 

28

 

-

Myeloblast

-

-

-

 

-

 

2

Mast cell

-

-

17

 

16

 

25

Tryptase (μg/L)

42.9

 

51.2

    

Histamine (nmol/L)††

-

 

1.2

    

IL-6 (pg/mL) †††

-

 

38.5

    

CRP (mg/dL)

-

85.6

225

 

30

 

55.9

LDH (U/L)

-

561

1221

 

-

 

5174

Treatments

Watch-wait

HU 1 g/L (×3 days)

leukaph. + HU 1.5 g/l (×3 days) + prednisolon 40 mg

İmatinib 300 mg/d + HU 0.5 g/d

leukaph. + Etoposide 50 mg

leukaph. + i.v. Cyclophos-phamide 1000 mg

EX

  1. Magnification: 160 X 135 mm
  2. by F.E.I.A ImmunoCAP PHADIA, N < 11.4, treshold 11.4/l : 95th percentile (Cerba Lab. Paris France, Ref no: 887821335110 and Ref no 9197749), †† by RIA (N < 10), †††by Electrochemiluminescence ECLIA Roche (N < 7).